表紙
市場調查報告書

日本的體外診斷 (IVD) 市場:診斷項目,企業,醫療費償付,波特五力分析,成長促進因素,課題,機會

Japan In Vitro Diagnostics (IVD) Market, By Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges

出版商 Renub Research 商品編碼 711739
出版日期 內容資訊 英文 144 Pages
商品交期: 最快1-2個工作天內
價格
日本的體外診斷 (IVD) 市場:診斷項目,企業,醫療費償付,波特五力分析,成長促進因素,課題,機會 Japan In Vitro Diagnostics (IVD) Market, By Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges
出版日期: 2020年05月01日內容資訊: 英文 144 Pages
簡介

本報告提供日本的體外診斷 (IVD)的市場相關分析,與市場基本結構和背景情況、政策環境,市場整體以及各部門趨勢預測,推動、阻礙市場要素向心力,主要企業的簡介、業績、策略等相關調查。

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 市場展望:日本的體外診斷 (VD) 市場

第5章 市場佔有率分析

第6章 日本的IVD市場:各部門

  • 尿液檢查
  • 血液檢驗
  • 臨床化學檢驗
  • 血糖自我監測
  • 腫瘤標記(癌症篩檢)
  • 免疫檢驗
  • 傳染病檢查
  • 細菌檢驗
  • 病理檢驗
  • 遺傳基因檢驗
  • 其他

第7章 波特的五力分析

  • 新加入企業的威脅
  • 買主談判力
  • 替代產品的威脅
  • 供應商談判力
  • 企業間的競爭關係

第8章 市場動態

  • 成長促進因素
  • 課題
  • 機會

第9章 醫療費償付政策

第10章 Abbott Laboratories:企業分析

  • 企業概要
  • 企業策略的發展情形
  • 財務分析

第11章 Danaher Corporation:企業分析

第12章 Biomerieux:企業分析

第13章 Roche Diagnostics:企業分析

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

As most of the industry growth rate in Japan is hit due to COVID-19, but on the contrary, Japan In-Vitro Diagnostics Market is expected to put an exceptional higher growth rate in 2020 compared to its past years (read the report for Coronavirus impact on IVD industry of Japan). According to our research report, Japan In-vitro Diagnostic Market is projected to reach US$ 4.43 Billion by 2026.

In-vitro Diagnostics falls under the medical devices segment, which is used by disposable & consumable, and it is also used in many different, different types of medical tones to find multiple bio-samples. In recent years, several developments have happened in the field of In-vitro diagnostics like conventional diagnostics to new generation gene diagnostics. This has become possible with the advent of new technologies, such as genetic testing, chain reaction (PCR), next-generation sequencing (NGS), and molecular diagnostics.

Factors driving the IVD Market in Japan

In Japan, a quarter of its population age 65 years & above and also has the highest proportion of the aging population across the globe. The main problem faced by the Japanese government in recent years is the rise in the number of an aging population, as the cases of aging diseases are multiplying. Accordingly, the Japanese government has given priority to deal with the aging population, and the government is expected to devote an expanded health budget to aging by 2025. This will boost the future of the Japanese In-Vitro Diagnostics Industry by rising prevalence and increased public expenditure.

Apart from that enhanced diagnostic technology, people's awareness and the subsequent growth in the prevalence of chronic and infectious diseases, a rise in the number of private hospitals, and independent testing laboratories are also some of the other factors that contribute to its market growth. Japan's clinical laboratory markets represent one of the largest and fastest-growing markets among the top ten IVD nation markets in the Asia Pacific regions.

Renub Research report titled "Japan In Vitro Diagnostics (IVD) Market, By Diagnostics (Tumor Marker, Urine & Feces, Clinical Chemistry, Hematology, Self Monitoring of Blood Glucose (SMBG), Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Abbott Laboratories, Danaher Corporation, Biomerieux, Roche Diagnostics, and Becton Dickinson), Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges" provides a complete analysis of Japan In Vitro Diagnostics (IVD) Market.

All the 11 Segments analysis of Japan In-Vitro Diagnostics Market

In this report, we have provided a complete analysis of 11 segments of the Japan In-vitro Diagnostic market. These segments are as follows Clinical Chemistry, Urine & Feces, Hematology, Tumor Marker, Self Monitoring Blood Glucose (SMBG), Immunology, Infectious disease, Microbiology, Pathology, Genetic Testing, and Others. In these In vitro diagnostics segments, we have done a comprehensive analysis of each segment due to COVID-19 along with separate growth factors for each segment.

Good Reimbursement Policy is expected ill further boost the Market of Japan In Vitro Diagnostics Market

Our report describes the scope and breadth of the reimbursement policies along with the full context. It also provides specific guidance and structure about how it operates and how Japanese authorities implement reimbursement policies. It describes how medical devices are categorized in Japan and which class In vitro diagnostic suits. It includes all medical manufacturers that have been in Japan for the past five years applying for reimbursement approval.

Porter's Five Forces Analysis

This research report provides a compressive study of all the 5 Porter's forces and their significant effect on Japan IVD industry.

BY Segment:

  • Urine & Faces Diagnostics
  • Hematology
  • Clinical Chemistry
  • Self-Blood Glucose Monitoring
  • Tumor Marker
  • Immunology
  • Infectious Testing
  • Microbiology
  • Pathology
  • Genetic Testing
  • Others

All the companies given in the report has been studied from two points

  • Recent Developments
  • Sales Analysis

Company Analysis:

  • Abbott Laboratories
  • Danaher Corporation
  • Biomerieux
  • Roche Diagnostics
  • Becton Dickinson

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summery

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges
  • 4.3 Opportunities

5. Porter's Five Forces Analysis

  • 5.1 Threat of New Entry
  • 5.2 The Bargaining Power of Buyer
  • 5.3 Threat of Substitution
  • 5.4 The Bargaining Power of Supplier
  • 5.5 Competitive Rivalry

6. Reimbursement Policy

7. Japan in Vitro Diagnostics Market

8. Market Share -Japan in Vitro Diagnostics

  • 8.1 By Segment

9. Segments - Japan in Vitro Diagnostics Market

  • 9.1 Urine & Faces Diagnostics
  • 9.2 Hematology
  • 9.3 Clinical Chemistry
  • 9.4 Self-Blood Glucose Monitoring
  • 9.5 Tumor Marker
  • 9.6 Immunology
  • 9.7 Infectious Testing
  • 9.8 Microbiology
  • 9.9 Pathology
  • 9.10 Genetic Testing
  • 9.11 Others

10. Company Analysis

  • 10.1 Abbott Laboratories
    • 10.1.1 Overview
    • 10.1.2 Recent Development/Strategy
    • 10.1.3 Sales
  • 10.2 Danaher Corporation
    • 10.2.1 Overview
    • 10.2.2 Recent Development/Strategy
    • 10.2.3 Sales
  • 10.3 Biomerieux
    • 10.3.1 Overview
    • 10.3.2 Recent Development/Strategy
    • 10.3.3 Sales
  • 10.4 Roche Diagnostics
    • 10.4.1 Overview
    • 10.4.2 Recent Development/Strategy
    • 10.4.3 Sales
  • 10.5 Becton
    • 10.5.1 Overview
    • 10.5.2 Recent Development/Strategy
    • 10.5.3 Sales

List of Figures

  • Figure-01: Japan- In-vitro Diagnostic Market size (Million US$), 2018 & 2024
  • Figure-02: Japan- In-vitro Diagnostic Top Two Rapid Growing Segment 2020 - 2026
  • Figure-03: Japan- In-vitro Diagnostic Largest Market Share, Immunology (Percent), 2019 -2026
  • Figure-04: Japan- Age-related disease type (Percentage), 2005 - 2016
  • Figure-05: Japan - Healthcare expenditure GDP( Percentage) 2018-2030
  • Figure-06: Japna - Healthcare expenditure market (Billion US$), 2005 - 2025
  • Figure-07: Japan- Government Healthcare Spending for 75 and older Population ( Billion US$), 2015 - 2025
  • Figure-08: Japan - In-vitro Diagnostics Market (Million US$), 2012 - 2019
  • Figure-09: Japan - Forecast for In-vitro Diagnostics Market (Million US$), 2020 - 2026
  • Figure-10: Japan- Urine & Faces Diagnostics Market (Million US$), 2012 - 2019
  • Figure-11: Japan- Forecast for Urine & Faces Diagnostics Market (Million US$), 2020 - 2026
  • Figure-12: Japan- Hematology Market (Million US$), 2012 - 2019
  • Figure-13: Japan- Forecast for Hematology Market (Million US$), 2020 - 2026
  • Figure-14: Japan- Clinical Chemistry Market (Million US$), 2012 - 2019
  • Figure-15: Japan- Forecast for Clinical Chemistry Market (Million US$), 2020 - 2026
  • Figure-16: Japan- SMBG Market (Million US$), 2012 - 2019
  • Figure-17: Japan- Forecast for SMBG Market (Million US$), 2020 - 2026
  • Figure-18: Japan- Tumor Marker Market (Million US$), 2012 - 2019
  • Figure-19: Japan- Forecast for Tumor Marker Market (Million US$), 2020 - 2026
  • Figure-20: Japan- Immunology Market (Million US$), 2012 - 2019
  • Figure-21: Japan- Forecast for Immunology Market (Million US$), 2020 - 2026
  • Figure-22: Japan- Infectious Disease Market (Million US$), 2012 - 2019
  • Figure-23: Japan- Forecast for Infectious Disease Market (Million US$), 2020 - 2026
  • Figure-24: Japan- Microbiology Testing Market (Million US$), 2012 - 2019
  • Figure-25: Japan- Forecast for Microbiology Testing Market (Million US$), 2020 - 2026
  • Figure-26: Japan - Pathology Market (Million US$), 2012 - 2019
  • Figure-27: Japan- Forecast for Pathology Market (Million US$), 2020 - 2026
  • Figure-28: Japan - Genetic Testing Market (Million US$), 2012 - 2019
  • Figure-29: Japan - Forecast for Genetic Testing Market (Million US$), 2020 - 2026
  • Figure-30: Japan- Others Segment Market (Million US$), 2012 - 2019
  • Figure-31: Japan - Forecast for Others Market (Million US$), 2020 - 2026
  • Figure-32: Abbott Laboratories - Global Diagnostic Sales (Million US$), 2015 - 2019
  • Figure-33: Abbott Laboratories - Global Forecast for Diagnostic Sales (Million US$), 2020 - 2026
  • Figure-34: Danaher Corporation - Global Diagnostic Sales (Million US$), 2015 - 2019
  • Figure-35: Danaher Corporation - Global Forecast for Diagnostic Sales (Million US$), 2020 - 2026
  • Figure-36: Biomerieux- Global Diagnostic Sales (Million US$), 2015 - 2019
  • Figure-37: Biomerieux - Global Forecast for Diagnostic Sales (Million US$), 2020 - 2026
  • Figure-38: Roche Diagnostics - Global Diagnostics Division sales (Million US$), 2015 - 2019
  • Figure-39: Roche Diagnostics - Global Forecast for Diagnostics Division sales (Million US$), 2020 - 2026
  • Figure-40: Becton - Global Diagnostics System sales (Million US$), 2015 - 2019
  • Figure-41: Becton - Global Forecast for Diagnostics System sales (Million US$), 2020 - 2026